Lumateperone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Addendum: Urinary incontinence with second-generation antipsychotic drugs.
Journal: The Medical letter on drugs and therapeutics
Published: February 23, 2026
Lumateperone (Caplyta) for adjunctive treatment of depression.
Journal: The Medical letter on drugs and therapeutics
Published: January 23, 2026
Mixed Symptoms in Mood Disorders: A Historical, Clinical, and Therapeutic Review
Journal: Vertex (Buenos Aires, Argentina)
Published: December 22, 2025
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis.
Journal: EClinicalMedicine
Published: December 11, 2025
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.
Journal: The American journal of psychiatry
Published: December 01, 2025
Reply: Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".
Journal: Journal of psychopharmacology (Oxford, England)
Published: November 27, 2025
Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".
Journal: Journal of psychopharmacology (Oxford, England)
Published: November 27, 2025
Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability.
Journal: Biomedicines
Published: November 24, 2025
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis.
Journal: International clinical psychopharmacology
Published: November 05, 2025
Lumateperone Safety and Tolerability in Schizophrenia: A Narrative Review.
Journal: Cureus
Published: November 04, 2025
The efficacy of lumateperone across symptoms of a major depressive episode with mixed features in patients with major depressive disorder and bipolar disorder: Post hoc analyses.
Journal: Journal of affective disorders
Published: November 03, 2025
Treatment of depressive episodes with mixed features: A systematic review and meta-analysis.
Journal: General hospital psychiatry
Published: October 28, 2025
Last Updated: 04/28/2026